|
- Generic Drugs: Questions Answers | FDA
Generic Drug Facts At-a-glance information on generic medicines, including why they may look different or cost less than brand-name medicines
- Generic Drug Facts | FDA
Generic drugs: Get the facts Consumer-friendly text and graphics provide a few facts about generic drug approval, quality, and performance
- First Generic Drug Approvals | FDA
FDA considers first generics to be important to public health, and prioritizes review of these submissions
- Generic Competition and Drug Prices | FDA
Estimated Savings from Generic Drug Approvals We recognize that there has been increasing attention on whether the lower cost of generic drugs, especially as more generics enter the market over
- Generic Drug Development | FDA
Potential ANDA applicants are encouraged to contact the FDA Generic Drugs Program with questions at any point in their development and application preparation processes If you have specific
- Complex Generics News | FDA
Generics of complex brand name drugs (i e , reference listed drugs) can be more difficult to develop As such, a complex drug may be less likely to have an available generic
- Office of Generic Drugs 2023 Annual Report | FDA
Our 2023 Annual Report provides highlights of activities and accomplishments including generic drug approvals, first generic approvals, science and research innovations for generic medicines
- Approved Drug Products with Therapeutic Equivalence Evaluations . . .
FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) identifies drug products approved on the basis of safety and effectiveness
|
|
|